







Shaping the Future Of Biotech








Full-Service CRO Excellence








Scientific Proficiency at the Core of Trials








Transcending Global Boundaries








Paving the Path to Regulatory Success










-
Shaping the Future Of Biotech
Offering decades of clinical research expertise, global compliance, and therapeutic experience to ensure your promising therapy isn’t delayed by risk or limited resources.
-
Full-service Excellence in Clinical Research
End-to-end solutions, from early-phase trials to post-marketing studies. Partner with us for comprehensive solutions that drive your success.
-
Scientific Proficiency at the Core of Trials
Empowering Innovation and Advancing Vital Therapies Across Diverse Therapeutic Areas, with Extensive Experience Supporting Over 275+ Clinical Trials across 15+ Therapeutic Domains.
-
Transcending Global Boundaries
With locations across the globe, we facilitate global trials with a localized touch, reducing time-to-market and ensuring broad accessibility.
-
Paving the Path to Regulatory Success
Honored with CPHI Pharma Awards 2023 for Regulatory Excellence, we expertly navigate the Regulatory landscape, for Swift Approvals and Compliance, leveraging our proven track record.
Capabilities
Comprehensive CRO capabilities spanning early to late-phase clinical development, supported by global operations, scientific expertise, and regulatory alignment.
Therapeutic Excellence
Advancing vital therapies across diverse therapeutic areas
Accelerating Biosimilar Development
Lambda holds a strong legacy in biosimilar development, covering a broad portfolio of molecules such as Adalimumab, Bevacizumab, Denosumab, Pertuzumab, Rituximab, Daratumumab, Trastuzumab, Trastuzumab Emtansine, Vedolizumab, Ranibizumab, Aflibercept, Teriparatide, Filgrastim, and Pegfilgrastim.
End-to-End Solutions
Full-service CRO Capabilities
Analytical Excellence
State-of-the-art lab with ELISA, ECLIA, IVD, Flow Cytometry & More


Accelerating Biosimilar Development
Lambda holds a strong legacy in biosimilar development, covering a broad portfolio of molecules such as Adalimumab, Bevacizumab, Denosumab, Pertuzumab, Rituximab, Daratumumab, Trastuzumab, Trastuzumab Emtansine, Vedolizumab, Ranibizumab, Aflibercept, Teriparatide, Filgrastim, and Pegfilgrastim.
End-to-End Solutions
Full-service offerings from Preclinical to Regulatory Support
Analytical Excellence
State-of-the-art lab with ELISA, ECLIA, IVD, Flow Cytometry & More


Why Lambda?
We combine comprehensive capabilities and global reach to support biotech and pharmaceutical companies with customized clinical development and resource solutions.
A Truly Global CRO with Multi-continental Presence
Comprehensive Clinical Research Services
Best Credit rating in CRO Industry
Strong Leadership with 20+ years of Experience
A Truly Global CRO with Multi-continental Presence
Comprehensive Clinical Research Services
Best Credit rating in CRO Industry
Strong Leadership with 20+ years of Experience


‘Regulatory & Compliance Excellence Award’ at the CPHI Pharma Awards 2023 for the exceptional work by Lambda in ‘Enhancing Compliance & Data Generation in Clinical Trials through Advanced Software Solutions and EDC Platform.’


‘Industry Partner of the Year’ Award
Global Generics & Biosimilar Awards 2023
Globally Recognized for Research Excellence
Featured Research and Insights
Our Presence
We are aggressively expanding globally and are confident in our research initiatives, propelling us toward a trajectory of excellence.


Corporate Office – Ahmedabad
Lambda House, Plot No. 38,
Survey No. 388, Near Silver Oak University,
S.G. Highway, Gota, Ahmedabad - 382481,
Gujarat, India.
Representative Office
Poland (Warsaw)
Representative Office
UK (London)
Representative Office
Canada (Toronto)
Representative Office
US (Las Vegas)
Representative Office
Spain (Barcelona)